Description

(3-Methyl-2-Oxo-3,4-Dihydroquinazolin-1(2H)-Yl)Acetic Acid (Saltdata: Free) is a high-purity quinazolinone derivative, a crucial building block in advanced pharmaceutical synthesis. This compound matters for its role as a key intermediate in developing novel therapeutic agents, offering researchers and manufacturers a reliable, high-quality starting material. It is primarily needed by R&D laboratories and production facilities in the pharmaceutical and agrochemical industries for creating active pharmaceutical ingredients (APIs) and other fine chemicals.

Application

• Pharmaceutical Intermediate: A critical precursor in the synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders and other therapeutic areas.
• Agrochemical Research: Serves as a key scaffold for developing new pesticides and herbicides with optimized efficacy and environmental profiles.
• Organic Synthesis Building Block: Used in academic and industrial research for constructing complex heterocyclic compounds and exploring new chemical spaces.
• Biochemical Probe Development: Utilized in medicinal chemistry to create probes for studying enzyme inhibition and biological pathway modulation.
• Fine Chemical Production: Employed in the manufacture of specialty chemicals requiring high-purity, complex organic structures.

Basic Information

Product Name	(3-Methyl-2-Oxo-3,4-Dihydroquinazolin-1(2H)-Yl)Acetic Acid (Saltdata: Free)
CAS No.	696637-93-1
Molecular Formula	C₁₁H₁₀N₂O₃
Molecular Weight	218.21 g/mol
Synonyms	1(2H)-Quinazolinoneacetic acid, 3,4-dihydro-3-methyl-2-oxo-; (3-Methyl-2-oxo-3,4-dihydroquinazolin-1(2H)-yl)acetic acid; 2-[(3-Methyl-2-oxo-4H-quinazolin-1-yl)]acetic acid; Quinazolinone acetic acid derivative; CAS 696637-93-1
EINECS	Contact for details

Quality Control

Our (3-Methyl-2-Oxo-3,4-Dihydroquinazolin-1(2H)-Yl)Acetic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via IR and NMR spectroscopy, to ensure it meets the high standards required for pharmaceutical intermediate applications. Certificates of Analysis (COA) documenting all specifications are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. This material is light-sensitive (store away from light).

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.